CDH Investments has led a $44 million series B round in logistics services firm Yimidida while Tasley Pharma completed its $20 million investment in Chinese drug developer Pegbio.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in